Critical.
Authoritative.
Strategic.
Subscribe to CIO Magazine »

Oracle buying drug-safety software maker

Move will boost Oracle's health sciences division

Oracle said Monday it is purchasing Relsys International, a maker of drug safety and risk management software, a move that ties into its ongoing strategy to tap verticals.

The deal is expected to close in the first half of this year. Terms were not disclosed.

Many of the world's largest pharmaceutical companies use Relsys' software, which pharmaceuticals, biotech companies and other organizations use to track and analyze safety-related data.

The Irvine, California, company will "bring significant domain knowledge and experience" to Oracle's health sciences global business unit, Oracle said in a statement.

Oracle's move "makes a lot of sense" given the political climate in the U.S., said Redmonk analyst James Governor.

"We're likely to see a stronger FDA and related approval processes under the Obama administration," Governor said. "Health care is also one of the verticals set to benefit from any big initiatives to fix U.S. health care."

But health care is not the only vertical Oracle is pursuing in search of new growth, and its battle against its rival in the ERP (enterprise resource planning) arena, SAP.

Last year, Oracle bought two companies that make software for the insurance industry. And in October, it scooped up Primavera, a top PPM (project portfolio management) vendor with customers in verticals such as construction and utilities.

Join the CIO Australia group on LinkedIn. The group is open to CIOs, IT Directors, COOs, CTOs and senior IT managers.

More about: Oracle, SAP

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.
Users posting comments agree to the CIO comments policy.
Login or register to link comments to your user profile, or you may also post a comment without being logged in.
Related Coverage
Related Whitepapers
Latest Stories
Community Comments
Tags: Biotechnology, oracle
Latest Blog Posts
Whitepapers
All whitepapers
rhs_login_lockGet exclusive access to Invitation only events CIO, reports & analysis.
Recent comments